Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
19 Diciembre 2024 - 5:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) will announce results for the
fourth quarter of 2024 on Thursday, February 6, 2025. Company
executives will review financial results and address inquiries from
investors and analysts during a conference call beginning at 8:00
a.m. ET on the same date.
Investors and the general public are invited to listen to a live
webcast of the call at http://investor.bms.com. Investors and the
public can register for the live conference call here. Those unable
to register can access the live conference call by dialing in the
U.S. toll free 1-833-816-1116 or international +1 412-317-0705.
Materials related to the call will be available at
http://investor.bms.com prior to the start of the conference
call.
A replay of the webcast will be available at
http://investor.bms.com approximately three hours after the
conference call concludes. A replay of the conference call will be
available beginning at 11:30 a.m. ET on February 6, 2025, through
11:30 a.m. ET on February 20, 2025, by dialing in the U.S. toll
free 1-877-344-7529 or international +1 412-317-0088, conference
code: 5943651.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241219830221/en/
Media: media@bms.com
Investors: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
